Karah Herdman Parschauer, EVP and Chief Legal Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 5,220 shares at $42.93 ($224K) on 2025-02-27, disclosed to the SEC on 2025-03-03.
Seasonal sale ($224k) by EVP and Chief Legal Officer — this insider has traded RARE in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.75 | 760 | $32K | 14.5% |
| 2 | $42.93 | 2,230 | $96K | 42.7% |
| 3 | $42.93 | 2,230 | $96K | 42.7% |
| Total | $42.90 avg | 5,220 | $224K | 100% |
| Filing → |
| RARE | SELL | 2026-03-10 | $208K | — | Filing → |
| RARE | SELL | 2026-03-03 | $185K | — | Filing → |
| RARE | SELL | 2025-09-12 | $153K | — | Filing → |